UPDATE: Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
14. Februar 2025 19:15 ET
|
UsAgainstAlzheimer's
Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
14. Februar 2025 18:20 ET
|
UsAgainstAlzheimer's
Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
Nine Levers Employers Can Use to Improve Brain Health and Workplace Performance
27. Januar 2025 09:00 ET
|
UsAgainstAlzheimer's
DAVOS, Switzerland, Jan. 27, 2025 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s (UsA2), the Davos Alzheimer's Collaborative (DAC) and the McKinsey Health Institute (MHI) teamed up to identify the most...
Business Collaborative for Brain Health Partners with HERO to Launch the Brain Health Best Practice Score for Employers
19. September 2024 13:30 ET
|
UsAgainstAlzheimer's
New educational tool will help companies assess how well their health and well-being programs support their workforce’s brain health, a critical factor in employees’ overall health, performance and...
UsAgainstAlzheimer’s Launches 2024 Brain Health Academy
16. April 2024 10:48 ET
|
UsAgainstAlzheimer's
WASHINGTON, April 16, 2024 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s today announced the return of its Brain Health Academy, scheduled to begin on May 9, 2024. First launched in 2022, the Academy...
Congress Passes Bills Making Major Investments in Alzheimer’s
23. März 2024 10:15 ET
|
UsAgainstAlzheimer's
Congress passes major investments in the fight against Alzheimer’s.
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s
08. März 2024 07:55 ET
|
UsAgainstAlzheimer's
WASHINGTON, March 08, 2024 (GLOBE NEWSWIRE) -- The maker of donanemab, Eli Lilly, announced today that the Food and Drug Administration (FDA) will convene an advisory committee to consider the...
Organizations Unite to Improve Brain Health
08. Februar 2024 11:52 ET
|
UsAgainstAlzheimer's
Washington, DC, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Today, UsAgainstAlzheimer’s, along with collaborators AARP, GN Group, Eli Lilly, and Novo Nordisk, launched the Business Collaborative for Brain...
Alzheimer’s Leaders Discuss How to Shift Science into Clinical Practice During National Alzheimer’s Summit
20. Oktober 2023 12:58 ET
|
UsAgainstAlzheimer's
Washington, DC, Oct. 20, 2023 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s this week hosted the 2023 National Alzheimer’s Summit, a groundbreaking event dedicated to applying recent scientific and...
UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s
06. Juli 2023 17:35 ET
|
UsAgainstAlzheimer's
Washington, DC, July 06, 2023 (GLOBE NEWSWIRE) -- Patient advocacy organization UsAgainstAlzheimer’s today hailed the first-of-its-kind traditional approval by the Food and Drug Administration (FDA)...